A Conversation With Vishwa Savla, CEO & Managing Director of Pinnacle Lifescience

An Exclusive Conversation With Vishwa Savla, CEO & Managing Director of Pinnacle Lifescience, Manufacturer of Capsules, Tablets, Pharmaceutical Items

In this exclusive conversation, Vishwa Savla, CEO and Managing Director of Pinnacle Lifescience, reflects on his journey of building a globally focused pharmaceutical company, driving innovation, quality, and affordable healthcare while steering the organization through dynamic, highly regulated international markets.

You’ve built Pinnacle in a very demanding industry like pharma. What was the moment that tested your leadership the most?

Vishwa Savla: There was a phase when we were expanding quickly while preparing for major global inspections. Everyone was stretched, and doubts naturally came in. I realised the team needed clarity more than motivation.

So, I brought everyone together, simplified the goals, and reminded them why we started. Once people reconnect with purpose, they find their strength again. That moment taught me what real leadership looks like.

People see the FDA approval today, not the struggle behind it. Did you ever feel the oncology facility might not pull through?

Vishwa Savla: Yes, many times. Oncology is a sensitive area, and the requirements are extremely strict. There were days when progress felt too slow.

But what kept me going was the belief that if we got this right, we could bring life-saving medicines to people who really need them. That thought was enough to push through the tough days.

Pinnacle is highly involved in cancer care, and the treatment is emotionally demanding. How did working in an oncology facility shape your perspective as a leader and as a person?

Vishwa Savla: Working in oncology changes you in ways you don’t expect. When you’re dealing with cancer care, you realise very quickly that this isn’t just another therapeutic area, it’s people’s toughest moments, their toughest fights. That awareness stays with you every day.

Every experience at Pinncle’s oncology segment made me far more mindful and grounded. Every decision feels personal because you know the end user is someone who is hoping for more time, more strength, more chances. It pushed me to slow down, listen more, and think beyond efficiencies or approvals.

And as a person, it taught me empathy at a much deeper level. You start valuing the small wins, the quiet progress, the responsibility that comes with making medicines people truly depend on. It reminded me that our work has a real impact and that purpose keeps me committed, focused, and grateful.

You work with scientists, regulators, operators, investors — all very different groups. What leadership lesson did you learn the hard way?

Vishwa Savla: That everyone needs information in a different way. Early on, I assumed one message would work for everyone. It doesn’t. Scientists think differently from investors, and regulators think differently from operators.

I learned to adjust how I communicate without changing the core message. It made collaboration much smoother.

What’s something about building a pharma company that no school or mentor can prepare you for?

Vishwa Savla: The waiting. Be it the approvals, audits or documentation, everything takes time. You can’t rush it, and you can’t control it.

You just learn patience, discipline, and the ability to stay calm even when progress feels slow. That’s something you can only learn in the pharma industry.

If you had to credit Pinnacle’s growth to one mindset, what would it be?

Vishwa Savla: For us, consistency and our focus on affordability and accessibility have been the real engines of growth.

We made a conscious decision early on not to chase quick wins or flashy milestones. Instead, we stayed committed to doing the right things daily, improving processes, strengthening teams, and ensuring our products remain reliable.

Over time, this quiet discipline built a foundation of trust, both within the company and in the global markets we serve.

You’ve worked in both regulated and emerging markets. What did these extremes teach you about impact?

Vishwa Savla: Regulated markets teach you accuracy, whereas emerging markets teach you empathy.

Together, they show that real impact in pharma is not just limited to the labs, it’s about making sure people everywhere can access safe, affordable medicines. That balance matters to me.

Pharma is changing fast. What are you preparing Pinnacle for that others will talk about only in the coming years?

Vishwa Savla: Pharma is moving toward a world where human expertise and intelligent systems will work hand-in-hand.

We’re getting ready for a future where decisions need to be quicker, data needs to be clearer, and processes need to be far more flexible than they are today.

Our goal is to build a company that remains stable yet moves quickly because that balance is what the industry will start discussing in a few years.

This engaging dialogue with Vishwa Savla highlights how clear vision, strategic leadership, and an unwavering focus on patients have propelled Pinnacle Lifescience forward, setting a strong example for aspiring healthcare leaders committed to improving global health outcomes through responsible, innovation-led growth.

Read more Success stories of Indian entrepreneurs, Women Entrepreneurs & startups stories at SugerMint. Follow us on Twitter, Instagram, Facebook, LinkedIn